| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.08 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |